期刊文献+

基因表达谱芯片筛选宫颈癌放疗抵抗差异表达基因 被引量:6

Differentially expressed genes in residual cervical cancer after radiotherapy screened by c DNA microarray
下载PDF
导出
摘要 目的探讨基因表达谱芯片筛选宫颈癌放疗残留癌组织与放疗前宫颈癌组织的差异表达基因。方法收集接受根治性放疗的宫颈癌患者3例,分别获取放疗至50 Gy残留癌组织和放疗前癌组织,通过基因表达谱芯片筛选出放疗前后的差异表达基因,应用荧光定量PCR对部分基因进行验证。结果基因表达谱芯片检测显示,放疗后残留癌组织表达上调3倍以上的基因有111个,表达下调3倍以上基因有127个。这些基因主要涉及DNA损伤修复、细胞周期调控、细胞粘附、细胞凋亡及自噬、细胞能量代谢、血管生成以及细胞信号转导等功能。荧光定量PCR证实CXCL12、CD74、FGF7、COL14A1、ATM和CD44基因在放疗后表达明显上调(P<0.05),而PRC1、RAD54L基因在放疗后表达明显下调(P<0.05)。结论基因表达谱芯片能筛选出宫颈癌放疗抵抗差异表达基因,为放疗敏感性的研究提供参考。 Objective To identify the differentially expressed genes in residual cervical cancer after radiotherapy by cDNA microarray. Methods Cervical cancer tissues from 3 patients before radiation and after 50 Gy dose of radiation were tested by cDNA mieroarray to select differentially expressed genes. The microarray results were validated by quantitative real-time PCR. Results Hier-archic cluster analysis identified that 238 differentiated genes exhibited ≥ 3.0-fold change, among which 111 genes were found to be in persistent up-regulation and 127 in persistent down-regulation after 50 Gy dose of radiation. These genes were involved in cell apoptosis and antophagy, cell energy metabolism, angiogenesis, cell apoptosis, cell cycle regulation, cell signaling, DNA damage repair, cell adhesion, and etc. The expression of CXCL12, CD74, FGF7, COL14A1, CD44 and ATM genes was up-regulated after radiation(P〈 0 05). Meanwhile, PRC1 and RAD54L were down-regulated after radiation (P 〈 0.05). Conclusion The differentially expressed genes identified by cDNA microarray are hoped to provide a foundation for the development of new diagnostic strategies and treatment for radiation resistance in cervical cancer.
出处 《临床肿瘤学杂志》 CAS 2016年第1期41-46,共6页 Chinese Clinical Oncology
基金 福建省自然科学基金资助项目(2014J01432 2015J01404)
关键词 宫颈癌 表达谱芯片 放疗抵抗 Cervical cancer Microarray Radiation resistance
  • 相关文献

参考文献11

  • 1Nakano T, Ohno T, Ishikawa H, et al. Current advancement in radiation therapy for uterine cervical cancer [ J ]. J Radiat Res, 2010,51(1) : 1-8.
  • 2胡尚英,郑荣寿,赵方辉,张思维,陈万青,乔友林.1989至2008年中国女性子宫颈癌发病和死亡趋势分析[J].中国医学科学院学报,2014,36(2):119-125. 被引量:212
  • 3Gadducci A, Tana R, Cosio S, et al. Treatment options in recur-rent cervical cancer (Review) [ J ]. Oncol Lett, 2010, 1 ( 1 ) : 3 -11.
  • 4Lirdprapamongkol K, Chiablaem K, Sila-Asna M, et al. Exploring stemness gene expression and vasculogenic mimicry capacity in well-and poorly-differentiated hepatocellular carcinoma cell lines [J]. Biochem Biophys Res Commun,2012,422(3) : 429-435.
  • 5Koeva M, Forsberg EC, Stuart JM. Computational integration of homolog and pathway gene module expression reveals general sternness signatures [ J/OL ]. PLoS One, 2011 [ 2015-07-20 ]. ht- tp ://www.nebi.ulra.nih.gov/pme/articles/PMC3084730.
  • 6Liu YL, Zhang C, Fan J, et al. Comprehensive analysis of clinical significance of stem-cell related factors in renal cell cancer[J]. World J Surg Oncol, 2011, 9:121.
  • 7Yin H, Glass J. The phenotypic radiation resistance of CD44+/ CD24(-or low) breast cancer cells is mediated through the en- hanced activation of ATM signaling [ J/OL ]. PLoS One, 2011 [ 2015-09-30]. http://www.ncbi.nlrn.nih.gov/pubmed/21935375.
  • 8Shen X, Artinyan A, Jackson D, et ah Chemokine receptor CX- CR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways [ J ]. Pancreas, 2010, 39 (1) :81-87.
  • 9Zhuo W, Jia L, Song N, et al. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis [ J ]. Clin Cancer Res, 2012, 18(19) :5387-5398.
  • 10Terasaki M, Sugita Y, Arakawa F. CXCL12/CXCR4 signaling i, malignant brain tumors: a potential pharmacological therapeutic target[J] .Brain Tumor Pathol, 2011,28(2) :89-97.

二级参考文献2

共引文献211

同被引文献57

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部